<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://xfzaixian.cn/articles/2lg-u6gq.html</loc>
    <news:news>
      <news:publication>
        <news:name>消费在线</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-07-01T01:00:04.000Z</news:publication_date>
      <news:title>2026消费赛道融资图谱：溜溜梅追觅鲟龙领衔 咖啡供应链与AI服装垂直平台获资本加码</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://xfzaixian.cn/articles/2lh-jt6j.html</loc>
    <news:news>
      <news:publication>
        <news:name>消费在线</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-07-01T01:00:04.000Z</news:publication_date>
      <news:title>中消协618维权报告7问：AI虚假测评如何识别 价保门槛怎避坑 举证难何解</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://xfzaixian.cn/articles/2m1-xinchayin-2025-fenhua.html</loc>
    <news:news>
      <news:publication>
        <news:name>消费在线</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-07-01T01:00:04.000Z</news:publication_date>
      <news:title>新茶饮&quot;五强&quot;2025年报全披露后分化加剧：古茗19.6亿港元可换股债撬动 奈雪连发10则回购仍创股价新低</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://xfzaixian.cn/articles/2ld-g8qy.html</loc>
    <news:news>
      <news:publication>
        <news:name>消费在线</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-06-30T01:00:04.000Z</news:publication_date>
      <news:title>重组胶原蛋白连续三年双位数增长后：增速放缓信号显现 头部格局加速生变</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://xfzaixian.cn/articles/2le-9f67.html</loc>
    <news:news>
      <news:publication>
        <news:name>消费在线</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-06-30T01:00:04.000Z</news:publication_date>
      <news:title>锦波生物增收不增利样本解析：薇旖美近400万支背后的利润困局与医美转型</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://xfzaixian.cn/articles/2lf-txda.html</loc>
    <news:news>
      <news:publication>
        <news:name>消费在线</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-06-30T01:00:04.000Z</news:publication_date>
      <news:title>消费品牌资本化路径横向对比：溜溜梅港股狂奔vs追觅700亿Pre-IPOvs鲟龙IPO竞速</news:title>
    </news:news>
  </url>
</urlset>